Table 7.

Laboratory evaluations and treatments

References	Country	Tests and treatments
Blank et al. [11]	Switzerland	Cost items, per month (used in a cost-effectiveness model) Alitretinoin 30 mg capsules: 28 × 30 mg (one capsule per day) Emollients: 200 g Pregnancy testing + oral contraceptives: 1 test, 21 tablets Lipid monitoring tests: 1 test PUVA/311 nm (topical/oral): 20 cycles per 10 weeks in a 6-month period (3.33 cycles per month) Topical corticosteroids: 60 g
Augustin et al. [14]	Germany	Diagnostics tests in the last 4 weeks: 1.7 Emollient products in the last 4 weeks: 1.3 Topical corticosteroid products in the last 4 weeks: 1.1 UV therapy (including PUVA) sessions in the last 4 weeks: 8.6
Cortesi et al. [15]	Italy	Mean (minimum–maximum) tests and treatments per patient-month Number of diagnostic tests (patch test, prick test, RAST, PRIST, atopy patch test, skin biopsy, test for hives, and immunofluorescence): 0.6 (0.0–2.1) Number of UV: 4.0 (4.0–4.0) Number of emollients: 1.2 (0.5–5.4) Number of galenic products: 1.1 (0.5–2.1) Number of other therapies (e.g. detergents/soaps, antiseptics): 0.8 (0.5–2.1)
Petersen et al. [23]	Denmark	Emollient use: 59% of patients Topical corticosteroid use: 64% of patients Systemic therapy: 7% of patients Phototherapy: 6% of patients

PRIST paper radioimmunosorbent test, PUVA psoralen-ultraviolet A therapy, RAST radioallergosorbent test, UV ultraviolet